Global Gene Transcriptome Analysis in Vaccinated Cattle Revealed a Dominant Role of IL-22 for Protection against Bovine Tuberculosis
Bovine tuberculosis (bTB) is a chronic disease of cattle caused by Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex group of bacteria. Vaccination of cattle might offer a long-term solution for controlling the disease and priority has been given to the development of a cattle vaccine against bTB. Identification of biomarkers in tuberculosis research remains elusive and the goal is to identify host correlates of protection. We hypothesized that by studying global gene expression we could identify in vitro predictors of protection that could help to facilitate vaccine development. Calves were vaccinated with BCG or with a heterologous BCG prime adenovirally vectored subunit boosting protocol. Protective efficacy was determined after M. bovis challenge. RNA was prepared from PPD-stimulated PBMC prepared from vaccinated-protected, vaccinated-unprotected and unvaccinated control cattle prior to M. bovis challenge and global gene expression determined by RNA-seq. 668 genes were differentially expressed in vaccinated-protected cattle compared with vaccinated-unprotected and unvaccinated control cattle. Cytokine-cytokine receptor interaction was the most significant pathway related to this dataset with IL-22 expression identified as the dominant surrogate of protection besides INF-γ. Finally, the expression of these candidate genes identified by RNA-seq was evaluated by RT-qPCR in an independent set of PBMC samples from BCG vaccinated and unvaccinated calves. This experiment confirmed the importance of IL-22 as predictor of vaccine efficacy.
Vyšlo v časopise:
Global Gene Transcriptome Analysis in Vaccinated Cattle Revealed a Dominant Role of IL-22 for Protection against Bovine Tuberculosis. PLoS Pathog 8(12): e32767. doi:10.1371/journal.ppat.1003077
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1003077
Souhrn
Bovine tuberculosis (bTB) is a chronic disease of cattle caused by Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex group of bacteria. Vaccination of cattle might offer a long-term solution for controlling the disease and priority has been given to the development of a cattle vaccine against bTB. Identification of biomarkers in tuberculosis research remains elusive and the goal is to identify host correlates of protection. We hypothesized that by studying global gene expression we could identify in vitro predictors of protection that could help to facilitate vaccine development. Calves were vaccinated with BCG or with a heterologous BCG prime adenovirally vectored subunit boosting protocol. Protective efficacy was determined after M. bovis challenge. RNA was prepared from PPD-stimulated PBMC prepared from vaccinated-protected, vaccinated-unprotected and unvaccinated control cattle prior to M. bovis challenge and global gene expression determined by RNA-seq. 668 genes were differentially expressed in vaccinated-protected cattle compared with vaccinated-unprotected and unvaccinated control cattle. Cytokine-cytokine receptor interaction was the most significant pathway related to this dataset with IL-22 expression identified as the dominant surrogate of protection besides INF-γ. Finally, the expression of these candidate genes identified by RNA-seq was evaluated by RT-qPCR in an independent set of PBMC samples from BCG vaccinated and unvaccinated calves. This experiment confirmed the importance of IL-22 as predictor of vaccine efficacy.
Zdroje
1. AshfordDA, WhitneyE, RaghunathanP, CosiviO (2001) Epidemiology of selected mycobacteria that infect humans and other animals. Revue scientifique et technique (International Office of Epizootics) 20: 325.
2. Krebs JR (1997) Bovine tuberculosis in cattle and badgers. London: Ministry of Agriculture, Fisheries and Food.
3. LiebanaE, JohnsonL, GoughJ, DurrP, JahansK, et al. (2008) Pathology of naturally occurring bovine tuberculosis in England and Wales. Vet J 176: 354–360.
4. HewinsonRG, VordermeierHM, BuddleBM (2003) Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis (Edinb) 83: 119–130.
5. VordermeierHM, ChambersMA, CocklePJ, WhelanAO, SimmonsJ, et al. (2002) Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70: 3026–3032.
6. SoysalA, MillingtonKA, BakirM, DosanjhD, AslanY, et al. (2005) Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. The Lancet 366: 1443–1451.
7. EwerK, MillingtonKA, DeeksJJ, AlvarezL, BryantG, et al. (2006) Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. American journal of respiratory and critical care medicine 174: 831.
8. VordermeierM, HewinsonRG (2006) Development of cattle TB vaccines in the UK. Vet Immunol Immunopathol 112: 38–48.
9. VordermeierHM, ChambersMA, BuddleBM, PollockJM, HewinsonRG (2006) Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle. Vet J 171: 229–244.
10. BuddleBM, WedlockDN, DenisM, SkinnerMA (2005) Identification of immune response correlates for protection against bovine tuberculosis. Vet Immunol Immunopathol 108: 45–51.
11. MaloneJH, OliverB (2011) Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol 9: 34.
12. VordermeierHM, Villarreal-RamosB, CocklePJ, McAulayM, RhodesSG, et al. (2009) Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun 77: 3364–3373.
13. Aranday-CortesE, HogarthPJ, KavehDA, WhelanAO, Villarreal-RamosB, et al. (2012) Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers. PLoS One 7: e30626.
14. NicolJW, HeltGA, BlanchardSGJr, RajaA, LoraineAE (2009) The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics 25: 2730–2731.
15. NakayaHI, LiS, PulendranB (2011) Systems vaccinology: learning to compute the behavior of vaccine induced immunity. Wiley Interdiscip Rev Syst Biol Med 4: 193–205.
16. McAleerJP, KollsJK (2011) Mechanisms controlling Th17 cytokine expression and host defense. J Leukoc Biol 90: 263–270.
17. SonnenbergGF, FouserLA, ArtisD (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383–390.
18. DhimanR, IndramohanM, BarnesPF, NayakRC, PaidipallyP, et al. (2009) IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol 183: 6639–6645.
19. ZengG, ChenCY, HuangD, YaoS, WangRC, et al. (2011) Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells. J Immunol 187: 190–199.
20. BesnardAG, SabatR, DumoutierL, RenauldJC, WillartM, et al. (2011) Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am J Respir Crit Care Med 183: 1153–1163.
21. LeeSJ, KohJY (2010) Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain 3: 30.
22. HarrisJ, MasterSS, De HaroSA, DelgadoM, RobertsEA, et al. (2009) Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages. Vet Immunol Immunopathol 128: 37–43.
23. ZhuXW, FriedlandJS (2006) Multinucleate giant cells and the control of chemokine secretion in response to Mycobacterium tuberculosis. Clin Immunol 120: 10–20.
24. El FenniriL, ToossiZ, AungH, El IrakiG, BourkkadiJ, et al. (2011) Polyfunctional Mycobacterium tuberculosis-specific effector memory CD4+ T cells at sites of pleural TB. Tuberculosis (Edinb) 91: 224–230.
25. JeyanathanM, MuJ, KugathasanK, ZhangX, DamjanovicD, et al. (2008) Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung. J Immunol 181: 5618–5626.
26. GarnierT, EiglmeierK, CamusJC, MedinaN, MansoorH, et al. (2003) The complete genome sequence of Mycobacterium bovis. Proceedings of the National Academy of Sciences 100: 7877.
27. FujitaPA, RheadB, ZweigAS, HinrichsAS, KarolchikD, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876–882.
28. MortazaviA, WilliamsBA, McCueK, SchaefferL, WoldB (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621–628.
29. BaggerlyKA, DengL, MorrisJS, AldazCM (2003) Differential expression in SAGE: accounting for normal between-library variation. Bioinformatics 19: 1477–1483.
30. KanehisaM, GotoS (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27–30.
31. Huang daW, ShermanBT, LempickiRA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1–13.
32. Huang daW, ShermanBT, LempickiRA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44–57.
33. De KetelaereA, GoossensK, PeelmanL, BurvenichC (2006) Technical note: validation of internal control genes for gene expression analysis in bovine polymorphonuclear leukocytes. J Dairy Sci 89: 4066–4069.
34. LivakKJ, SchmittgenTD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 25: 402–408.
35. SchmittgenTD, LivakKJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101–1108.
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2012 Číslo 12
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses
- Parallels in Intercellular Communication in Oomycete and Fungal Pathogens of Plants and Humans
- Virus-Encoded microRNAs: An Overview and a Look to the Future
- Reactive Oxygen Species Production and Survivorship in with Artificial Infection Types